Samarys Peek Anterior Cervical Cage 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 B Braun Australia Pty Ltd 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2015-RN-01246-1
  • 사례 위험등급
    Class I
  • 사례 시작날짜
    2015-12-21
  • 사례 국가
  • 사례 출처
    DHTGA
  • 사례 출처 URL
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    This hazard alert is being issued because of a random non-conformity relevant to the gold wires used as a position marker for the cervical peek cage samarys. the observed facts were that some devices within 4 lots manufactured between april 2014 and november 2015 presented missing, improperly secured, and/or incorrectly positioned gold wire markers, which may protrude 1-2 mm inside or outside the cage.Gold wires protruding from cage may cause local inflammation and/or neural or vascular injuries at treated site or distant ones by migration (in complete protrusion), which potentially can have serious consequences. the probability of these potential adverse events is however very low. to date, no customer complaint has been recorded and no adverse event or incident has been reported.
  • 조치
    The sponsor is advising the surgeons that in the case of improper fixation of the gold wire, migration of these small dimensioned gold wires in the surrounding tissues would be easily detected on the X-ray films that are routinely taken during patient follow-up. Additionally, as exposed subjects may be often asymptomatic for a long period, surgeons must check on the routine X-ray films that position markers did not migrate. They may also warn implanted patients to report any late dysphagia, sensation of foreign bodies into their throat or suspect cough or different concerning symptoms, as this might allow early detecting a potential complication and solving it. For further information, please see http://www.tga.gov.au/alert/samarys-polyethylethylketone-anterior-cervical-cage This action has been closed-out on 30/08/2016.

Device

  • 모델명 / 제조번호(시리얼번호)
    Samarys Peek Anterior Cervical CageUnits from the following batches of Samarys Peek Anterior Cervical Cage are affected.Part No: 11CC2A15-5S Lot No:23LJ-19196Part No: 11CC2A17-6S Lot No: 23KY+19029Part No: 11CC2AC17-5S Lot No: 247P+19029Part No: 11CC2AC17-6S Lot No: 248K+19029ARTG Number: 101789
  • Manufacturer

Manufacturer